Search Results

multidisciplinary breast cancer experts voted (24 For, 0 Against, 1 Abstain) in favor of maintaining the current position and recommendation in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer on the use of bevacizumab (Avastin

comments about the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), articles published in the journal, or any other topic relating to cancer prevention, detection, treatment, supportive care, or survivorship. Please send correspondence

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Kidney Cancer, published in this issue (page 71), include the latest updates. To assist readers interested in noting how the guidelines were updated, highlights of major

NCCN continues to add to the library of NCCN Chemotherapy Order Templates (NCCN Templates) to improve the safe use of drugs and biologics in cancer care. The NCCN Templates, derived from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines

NCCN Guidelines® Updates: AIDS-Related Kaposi Sarcoma The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for AIDS-Related Kaposi Sarcoma published in this issue (page 171) include the latest updates. To assist readers interested in

, visit NCCN.org . NCCN Releases New Translations of NCCN Guidelines NCCN recently posted new translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hodgkin Lymphoma, Multiple Myeloma, Non-Hodgkin’s Lymphomas, and

choice by prior NCCN guidance on advanced colorectal cancer. 2 The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer 2 had endorsed FOLFIRI as second-line therapy for advanced colorectal cancer, with or without ziv

Shortenhaus, Lilly Oncology, PACE Program Beckie VonRuden, Mayo Clinic Cancer Center, Patient Perspective On-site demonstrations of the following value tools were available to attendees: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines

clinical trials conducted in our country. Using the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer at only one specific point in time as the “gold standard” may not be the most precise way to measure deviations of standard

quality, effective, efficient, and accessible cancer care so patients can live better lives under any circumstances. The organization has continued posting new updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)—which contain